Josh Denny Will Lead UChicago AI Initiatives

The NIH executive will assume his new role as UChicago Medicine's senior vice president and chief data officer in November 2026.

Updated on Sept. 28, 2026 in People

Josh Denny Will Lead UChicago AI Initiatives

Live Poll

Do you believe integrating AI into medical systems will ultimately lead to better patient outcomes?

University of Chicago Medicine has appointed Josh Denny as senior vice president for AI and precision medicine and chief data officer. He is set to begin his new position in November 2026, working across the health system, research division, and university.

Why it matters

The appointment supports the UChicago Medicine Elevate 2035 strategic plan, which aims to integrate clinical care with advanced research and technology. By uniting AI, genomics, and informatics, the institution seeks to bridge the gap between patient data and medical breakthroughs.

The NIH All of Us Research Program has enrolled nearly 900,000 participants and generated more than 535,600 whole genome sequences. Locally, the Illinois Precision Medicine Consortium has enrolled over 62,000 participants statewide.

The players

Josh Denny

He is the current CEO of the NIH All of Us Research Program and a former leader at the Vanderbilt Health Center for Precision Medicine.

University of Chicago Medicine

This is a leading academic health system based in Chicago that focuses on integrating clinical care with medical research.

The details

Denny will oversee efforts to connect AI and genomics with clinical informatics, building on his previous work developing phenome-wide association studies to scan patient records. His transition to Chicago follows a career that includes two decades at Vanderbilt Health and his current leadership of the All of Us Research Program.

2020: Josh Denny began his tenure as CEO of the All of Us Research Program.
November 2026: Josh Denny begins his role as UChicago AI chief.

Market Landscape

This move reflects a broader trend of academic medical centers recruiting high-level talent to industrialize the use of AI in clinical settings. By aligning leadership with the UChicago Medicine Elevate 2035 strategic plan, the system positions itself to compete with other major research hubs.

Patients within the UChicago Medicine system may eventually see more personalized treatment plans driven by the integration of their genetic data and clinical records. These improvements are intended to streamline diagnosis and care pathways through the university's research-led approach.

The takeaway

The addition of a high-profile executive to lead AI initiatives signals an accelerated focus on data-driven medicine in Chicago. Future developments will likely center on how patient genomic data is successfully translated into daily clinical practice.